Transform healthcare sectors toward an accessible, equitable, and sustainable system by investing in AI, automation, and robotics platforms that improve access and quality of care for patients globally.
Create the foundation for a more sustainable and peaceful society by improving human health and lifespan through technology that scales access, efficiency, and quality of healthcare.
Sigma Capital is an evergreen investment platform focused on companies transforming healthcare through AI, automation, and robotics. Today, many patients lack access to affordable care when it matters most. Technology can scale access, efficiency, and quality of human healthcare, particularly in cost and labor-intensive, critical care settings.
Rooted in a European industrial family with global scale in software, automation, energy, and healthcare, Sigma Capital has deep relationships with top-tier academic research institutions and strong access to EU and US healthcare stakeholders. With presence in Abu Dhabi, Berlin, Chicago, London, and San Francisco, we invest and provide capital grants to platforms with daring objectives to improve access and quality of care for patients.
Our mission is to transform healthcare sectors toward an accessible, equitable, and sustainable system. We support entrepreneurial and innovative organizations delivering solutions to patients, hospitals, insurers, laboratories, med-tech, and government stakeholders—creating the foundation for a more sustainable and peaceful society.
Sigma Capital, owned by Bjoern von Siemens, builds on and continues the Siemens family's commitment to advancing healthcare through technology—from pioneering medical devices to AI-powered digital health platforms. Across operational, investment, and foundation activities, we are making a positive impact in the healthcare ecosystem and beyond, creating the foundation for a more sustainable and peaceful society.
TIME magazine recognized Caresyntax as one of the World's Top HealthTech Companies of 2025, ranking "Outstanding" among the top 25 companies globally based on financial performance, reputation, and impact.
Read on LinkedIn →Exploring Werner von Siemens' birthplace in Lenthe and the family's ancestral home in Goslar—connecting 175+ years of innovation from telegraph systems to modern surgical AI.
Read on LinkedIn →Caresyntax recognized as the only Surgical Intelligence company in TIME & Statista's AI & Analytics category, turning operating room data into actionable insights that improve patient safety and clinical decisions.
Read on LinkedIn →Named among LSI's Hot 3 MedTech Startups, Caresyntax is closing the gap in surgical digitalization—bringing AI-enabled precision surgery to millions worldwide through automation and data-driven decision support.
Read on LinkedIn →At Tech Tour Growth Health 2025, discussing what it takes to scale digital health—moving beyond proof-of-concept to system-wide platforms that align innovation, regulation, and trust across the healthcare ecosystem.
Read on LinkedIn →Announcing the appointment of Matt Krueger as CEO of Caresyntax after six years of partnership. Supporting 10 million surgeries annually across 4,200 operating rooms—and backing this transition with a personal 7-figure investment.
Read on LinkedIn →Through its support of the Werner Siemens-Stiftung, Sigma Capital contributes to pioneering research in science and technology. The Foundation focuses on breakthrough innovations that address critical challenges—from quantum computing and sustainable energy to advanced medical technologies—bridging the crucial gap between basic research and commercial application.